Ann: Appendix 4D & Interim Financial Report 31 December 2014, page-2

In line with my expectations. Will read into the details tonight, but initially I liked seeing that a 3rd oncology pilot group has signed on. Staff costs have increased a lot, but i would be unimpressed if it hadn't, because I hope we have lots of sale staff out there selling the benefits of our product and the Medicare reimbursement! Still have $38 mil in the bank so very well capitalised. I see we had a benefit of over $1mil from currency conversion, is that right? The company keeps all its cash in USD due to the majority of expenses being in USD.

Just need the final 3 pilot groups signed on, then it's a ramp up to full commercial rollout towards the end of the year!